marketcaparena

NATR

NATURES SUNSHINE PRODUCTS INC

Company overview

Market capitalization
$225.75M
Employees
806
Latest publication
2026-09-29
About NATURES SUNSHINE PRODUCTS INC

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system. It also offers cardiovascular products; digestive products to regulate intestinal and digestive functions; personal care products for external use, including oils and lotions, aloe vera gel, herbal shampoo, herbal skin treatment, toothpaste, and skin cleanser. In addition, the company provides weight management products, such as meal replacements and products that increase caloric burn rate. It offers its products under the Nature's Sunshine and Synergy Worldwide brands through its network of independent consultants to customers. Nature's Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Revenue122,892,000USD123,807,000USD128,339,000USD114,750,000USD113,248,000USD118,205,000USD114,615,000USD110,551,000USD
Cost Of Revenue32,915,000USD34,028,000USD34,290,000USD32,451,000USD31,651,000USD33,141,000USD32,856,000USD31,664,000USD
Gross Profit89,977,000USD89,779,000USD94,049,000USD82,299,000USD81,597,000USD85,064,000USD81,759,000USD78,887,000USD
Selling General Administrative43,539,000USD48,418,000USD45,726,000USD43,665,000USD40,581,000USD43,709,000USD40,954,000USD38,557,000USD
Selling And Marketing Expenses36,893,000USD36,039,000USD39,348,000USD34,360,000USD34,844,000USD36,805,000USD35,521,000USD34,693,000USD
Total Operating Expenses80,432,000USD84,457,000USD85,074,000USD78,025,000USD75,425,000USD80,514,000USD76,475,000USD73,250,000USD
Operating Income9,545,000USD5,322,000USD8,975,000USD4,274,000USD6,172,000USD4,550,000USD5,284,000USD5,637,000USD
Interest Income74,000USD121,000USD51,000USD268,000USD205,000USD——412,000USD
Interest Expense35,000USD27,000USD26,000USD24,000USD21,000USD—39,000USD103,000USD
Net Interest Income39,000USD94,000USD25,000USD244,000USD184,000USD—-39,000USD309,000USD
Income Before Tax8,155,000USD5,487,000USD9,672,000USD7,544,000USD7,109,000USD1,449,000USD7,899,000USD4,423,000USD
Income Tax Expense3,037,000USD974,000USD4,136,999USD2,025,000USD2,225,000USD2,181,000USD3,253,000USD2,935,000USD
Tax Provision3,037,000USD974,000USD4,137,000USD2,025,000USD2,225,000USD2,181,000USD3,253,000USD2,935,000USD
Net Income5,118,000USD4,107,000USD5,334,000USD5,333,000USD4,747,000USD-321,000USD4,347,000USD1,349,000USD
Net Income From Continuing Ops5,118,000USD4,513,000USD5,535,000USD5,519,000USD4,884,000USD-732,000USD4,646,000USD1,488,000USD
Ebit8,190,000USD5,514,000USD9,672,000USD7,568,000USD7,130,000USD3,027,000USD7,899,000USD4,423,000USD
Ebitda11,414,000USD8,820,000USD13,211,000USD11,068,000USD10,629,000USD7,051,000USD11,435,000USD7,922,000USD
Depreciation And Amortization3,224,000USD3,306,000USD3,539,000USD3,500,000USD3,499,000USD4,024,000USD3,536,000USD3,499,000USD
Reconciled Depreciation3,224,000USD3,306,000USD3,539,000USD3,500,000USD3,499,000USD4,024,000USD3,536,000USD3,499,000USD
Total Other Income Expense Net-1,390,000USD165,000USD697,000USD3,270,000USD937,000USD-3,101,000USD2,615,000USD-1,214,000USD
Minority Interest0USD-406,000USD-201,000USD-186,000USD-137,000USD411,000USD-299,000USD-139,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20222022-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20142014-12-31 · USDFY 20132013-12-31 · USD
Total Revenue480,144,000USD454,364,000USD421,910,000USD362,215,000USD364,810,000USD342,029,000USD366,367,000USD378,096,000USD
Cost Of Revenue132,420,000USD129,676,000USD122,150,000USD93,940,000USD95,691,000USD91,037,000USD91,584,000USD94,814,000USD
Gross Profit347,724,000USD324,688,000USD299,760,000USD268,275,000USD269,119,000USD250,992,000USD274,783,000USD283,282,000USD
Research Development1,900,000USD1,700,000USD1,500,000USD2,100,000USD2,800,000USD3,400,000USD2,500,000USD2,000,000USD
Selling General Administrative178,390,000USD164,004,000USD153,125,000USD128,740,000USD138,431,000USD129,635,000USD119,927,000USD120,743,000USD
Selling And Marketing Expenses144,591,000USD140,589,000USD130,377,000USD123,410,000USD——135,808,000USD138,482,000USD
Total Operating Expenses322,981,000USD304,593,000USD283,502,000USD252,150,000USD263,768,000USD249,605,000USD255,735,000USD259,225,000USD
Operating Income24,743,000USD20,095,000USD16,258,000USD16,125,000USD5,351,000USD1,387,000USD19,048,000USD24,057,000USD
Interest Income645,000USD177,000USD123,000USD262,000USD67,000USD144,000USD——
Interest Expense98,000USD146,000USD249,000USD43,000USD387,000USD289,000USD187,000USD231,000USD
Net Interest Income547,000USD31,000USD-126,000USD219,000USD-387,000USD-145,000USD——
Income Before Tax29,812,000USD18,426,000USD15,215,000USD15,642,000USD3,200,000USD3,222,000USD19,014,000USD25,653,000USD
Income Tax Expense9,361,000USD10,534,000USD14,665,000USD8,713,000USD4,402,000USD17,039,000USD-743,000USD8,044,000USD
Tax Provision9,361,000USD10,534,000USD14,665,000USD8,713,000USD4,402,000USD17,039,000USD——
Net Income19,521,000USD7,696,000USD-390,000USD6,765,000USD-854,000USD-12,942,000USD10,019,000USD17,609,000USD
Net Income From Continuing Ops20,451,000USD7,892,000USD550,000USD6,929,000USD-1,202,000USD-13,817,000USD19,757,000USD17,609,000USD
Ebit29,910,000USD18,572,000USD15,464,000USD15,685,000USD3,587,000USD1,387,000USD21,248,000USD26,283,000USD
Ebitda43,754,000USD32,791,000USD31,146,000USD26,284,000USD13,487,000USD10,021,000USD25,657,000USD30,749,000USD
Depreciation And Amortization13,844,000USD14,219,000USD15,682,000USD10,599,000USD9,900,000USD8,634,000USD4,409,000USD4,466,000USD
Reconciled Depreciation13,844,000USD14,219,000USD11,025,000USD10,599,000USD9,806,000USD8,634,000USD——
Total Other Income Expense Net5,069,000USD-1,669,000USD-1,043,000USD-483,000USD-2,151,000USD1,835,000USD-34,000USD1,596,000USD
Minority Interest-930,000USD-196,000USD940,000USD164,000USD-348,000USD-875,000USD-219,000USD—
Non Operating Income Net Other——-1,043,000USD-483,000USD-2,151,000USD1,835,000USD-34,000USD1,596,000USD
Net Income Applicable To Common Shares——-390,000USD6,765,000USD-854,000USD-12,942,000USD10,019,000USD17,609,000USD
Unclassified Operating Expenses————122,537,000USD116,570,000USD——
Discontinued Operations——————-9,957,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Total Assets261,458,000USD261,146,000USD264,805,000USD254,875,000USD252,702,000USD240,855,000USD245,333,000USD235,831,000USD
Other Current Assets11,330,000USD8,040,000USD8,081,000USD8,144,000USD7,955,000USD6,959,000USD11,131,000USD9,747,000USD
Total Liab94,542,000USD99,593,000USD98,101,000USD91,193,000USD85,602,000USD79,864,000USD82,716,000USD79,431,000USD
Total Stockholder Equity166,916,000USD161,553,000USD160,502,000USD157,681,000USD161,285,000USD155,313,000USD156,528,000USD150,610,000USD
Other Current Liab50,999,000USD56,704,000USD56,794,000USD50,039,000USD47,556,000USD43,637,000USD45,969,000USD45,138,000USD
Common Stock102,252,000USD102,192,000USD103,553,000USD104,662,000USD115,146,000USD114,577,000USD113,946,000USD114,014,000USD
Capital Stock102,252,000USD102,192,000USD103,553,000USD104,662,000USD115,146,000USD114,577,000USD113,946,000USD114,014,000USD
Retained Earnings82,046,000USD76,928,000USD72,821,000USD67,487,000USD62,154,000USD57,407,000USD57,728,000USD53,381,000USD
Cash87,578,000USD93,891,000USD95,554,000USD81,345,000USD86,486,000USD84,700,000USD78,704,000USD68,695,000USD
Cash And Short Term Investments87,578,000USD93,891,000USD95,554,000USD81,345,000USD86,486,000USD84,700,000USD78,704,000USD68,695,000USD
Total Current Assets178,588,000USD178,845,000USD186,084,000USD171,838,000USD170,782,000USD160,579,000USD163,529,000USD152,036,000USD
Total Current Liabilities71,366,000USD78,538,000USD83,649,000USD75,854,000USD70,741,000USD65,692,000USD67,150,000USD63,649,000USD
Current Deferred Revenue2,780,000USD5,840,000USD7,536,000USD5,501,000USD2,487,000USD2,774,000USD1,747,000USD2,217,000USD
Net Debt-65,148,000USD-74,991,000USD-81,266,000USD-65,715,000USD-71,638,000USD-70,496,000USD-63,430,000USD-53,344,000USD
Short Term Debt4,367,000USD3,270,000USD4,601,000USD4,625,000USD4,291,000USD3,927,000USD4,037,000USD3,961,000USD
Short Long Term Debt Total22,430,000USD18,900,000USD14,288,000USD15,630,000USD14,848,000USD14,204,000USD15,274,000USD15,351,000USD
Net Receivables12,549,000USD8,602,000USD15,114,000USD13,029,000USD11,413,000USD9,477,000USD11,396,000USD11,290,000USD
Inventory67,131,000USD68,312,000USD67,335,000USD69,320,000USD64,928,000USD59,443,000USD62,298,000USD62,304,000USD
Accounts Payable8,251,000USD8,021,000USD7,119,000USD9,924,000USD9,865,000USD8,912,000USD8,875,000USD8,422,000USD
Property Plant Equipment Net51,788,000USD50,515,000USD46,935,000USD50,148,000USD51,162,000USD52,384,000USD55,809,000USD58,554,000USD
Property Plant Equipment Gross51,788,000USD158,659,000USD46,935,000USD50,148,000USD51,162,000USD150,212,000USD55,809,000USD58,554,000USD
Accumulated Other Comprehensive Income-17,382,000USD-17,566,999USD-15,872,000USD-14,468,000USD-16,015,000USD-16,671,000USD-15,146,000USD-16,785,000USD
Common Stock Shares Outstanding17,929,000shares17,922,000shares18,034,000shares18,966,000shares18,846,000shares18,479,000shares18,890,000shares19,119,000shares
Non Current Assets Total82,870,000USD82,301,000USD78,721,000USD83,037,000USD81,920,000USD80,276,000USD81,804,000USD83,795,000USD
Non Current Liabilities Total23,176,000USD21,055,000USD14,452,000USD15,339,000USD14,861,000USD14,172,000USD15,566,000USD15,782,000USD
Non Current Liabilities Other2,605,000USD2,911,000USD2,139,000USD1,646,000USD1,580,000USD1,345,000USD1,440,000USD1,403,000USD
Non Currrent Assets Other10,396,000USD10,586,000USD11,426,000USD11,479,000USD10,739,000USD10,248,000USD10,162,000USD9,647,000USD
Net Working Capital107,222,000USD100,307,000USD102,435,000USD95,984,000USD100,041,000USD94,887,000USD96,379,000USD88,387,000USD
Unclassified Non Current Assets20,686,000USD21,200,000USD20,360,000USD21,410,000USD20,019,000USD17,644,000USD14,941,000USD14,703,999USD
Unclassified Current Liabilities4,969,000USD4,703,000USD7,599,000USD5,765,000USD6,542,000USD6,442,000USD6,522,000USD3,911,000USD
Unclassified Non Current Liabilities20,571,000USD18,144,000USD12,313,000USD13,693,000USD13,281,000USD12,827,000USD14,126,000USD14,379,000USD
Unclassified Equity-102,252,000USD-102,192,001USD-103,553,000USD-104,662,000USD-115,146,000USD-114,577,000USD-113,946,000USD-114,014,000USD
Long Term Investments——————892,000USD890,000USD
Other Assets———————1USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets261,146,000USD240,855,000USD249,773,000USD229,778,000USD258,874,000USD249,498,000USD213,068,000USD193,016,000USD
Other Current Assets8,040,000USD6,959,000USD7,722,000USD7,420,000USD8,760,000USD6,938,000USD5,091,000USD6,388,000USD
Total Liab99,593,000USD79,864,000USD90,233,000USD82,731,000USD97,470,000USD92,264,000USD83,632,000USD72,448,000USD
Total Stockholder Equity161,553,000USD155,313,000USD154,058,000USD142,905,000USD158,202,000USD155,386,000USD129,209,000USD120,505,000USD
Other Current Liab56,704,000USD43,637,000USD52,739,000USD44,667,000USD51,562,000USD47,935,000USD41,594,000USD55,363,000USD
Common Stock102,192,000USD114,577,000USD119,694,000USD121,583,000USD133,382,000USD139,311,000USD135,741,000USD133,684,000USD
Capital Stock102,192,000USD114,577,000USD119,694,000USD121,583,000USD133,382,000USD139,311,000USD135,741,000USD133,684,000USD
Retained Earnings76,928,000USD57,407,000USD49,711,000USD34,635,000USD35,025,000USD26,030,000USD4,693,000USD-2,072,000USD
Cash93,891,000USD84,700,000USD82,373,000USD60,032,000USD86,184,000USD92,069,000USD53,629,000USD50,638,000USD
Cash And Short Term Investments93,891,000USD84,700,000USD82,373,000USD60,032,000USD86,184,000USD92,069,000USD53,629,000USD50,638,000USD
Total Current Assets178,845,000USD160,579,000USD165,817,000USD149,507,000USD164,667,000USD154,065,000USD112,705,000USD106,825,000USD
Total Current Liabilities78,538,000USD65,692,000USD76,753,000USD65,582,000USD76,670,000USD69,654,000USD57,947,000USD66,687,000USD
Current Deferred Revenue5,840,000USD2,774,000USD1,794,000USD2,255,000USD3,694,000USD2,092,000USD1,266,000USD1,197,000USD
Net Debt-74,991,000USD-70,496,000USD-67,450,000USD-40,847,000USD-63,195,000USD-65,741,000USD-26,957,000USD-49,108,000USD
Short Term Debt3,270,000USD3,927,000USD4,547,000USD5,440,000USD5,896,000USD7,498,000USD6,459,000USD1,530,000USD
Short Long Term Debt Total18,900,000USD14,204,000USD14,923,000USD19,185,000USD22,989,000USD26,328,000USD26,672,000USD1,530,000USD
Net Receivables8,602,000USD9,477,000USD8,827,000USD14,106,000USD8,871,000USD7,375,000USD7,319,000USD7,751,000USD
Inventory68,312,000USD59,443,000USD66,895,000USD67,949,000USD60,852,000USD47,683,000USD46,666,000USD42,048,000USD
Accounts Payable8,021,000USD8,912,000USD7,910,000USD6,349,000USD9,702,000USD6,486,000USD4,406,000USD5,219,000USD
Property Plant Equipment Net50,515,000USD52,384,000USD58,361,000USD62,307,000USD69,206,000USD74,565,000USD83,463,000USD64,061,000USD
Property Plant Equipment Gross158,659,000USD150,212,000USD153,117,000USD62,307,000USD69,206,000USD74,565,000USD83,463,000USD64,061,000USD
Accumulated Other Comprehensive Income-17,566,999USD-16,671,000USD-15,347,000USD-13,313,000USD-10,205,000USD-9,955,000USD-11,225,000USD-11,107,000USD
Common Stock Shares Outstanding18,468,000shares18,616,000shares19,466,000shares19,326,000shares20,327,000shares19,968,000shares19,663,000shares19,123,000shares
Non Current Assets Total82,301,000USD80,276,000USD83,956,000USD80,271,000USD94,207,000USD95,433,000USD100,363,000USD86,191,000USD
Non Current Liabilities Total21,055,000USD14,172,000USD13,480,000USD17,149,000USD20,800,000USD22,610,000USD25,685,000USD5,761,000USD
Non Current Liabilities Other2,911,000USD1,345,000USD644,000USD15,008,000USD17,096,000USD16,412,000USD20,213,000USD2,897,000USD
Non Currrent Assets Other10,586,000USD10,248,000USD10,531,000USD11,105,000USD11,411,000USD12,175,000USD11,434,000USD11,148,000USD
Net Working Capital100,307,000USD94,887,000USD89,064,000USD83,925,000USD87,997,000USD84,411,000USD54,758,000USD40,138,000USD
Unclassified Non Current Assets21,200,000USD17,644,000USD15,063,999USD-12,643,000USD-11,411,000USD-12,175,000USD-11,434,000USD-12,456,000USD
Unclassified Current Liabilities4,703,000USD6,442,000USD9,763,000USD5,697,000USD4,270,000USD3,137,000USD2,704,000USD1,848,000USD
Unclassified Non Current Liabilities18,144,000USD12,827,000USD12,836,000USD-3,404,000USD-3,707,000USD——-2,897,000USD
Unclassified Equity-102,192,001USD-114,577,000USD-119,694,000USD-121,583,000USD-133,382,000USD-139,311,000USD-135,741,000USD-133,684,000USD
Other Assets——1USD17,964,000USD25,001,000USD20,868,000USD16,333,000USD21,512,000USD
Intangible Assets———1,538,000USD——567,000USD618,000USD
Deferred Long Term Liab———2,141,000USD2,530,000USD———
Other Liab———3,404,000USD3,707,000USD3,780,000USD5,472,000USD5,761,000USD
Short Long Term Debt———1,174,000USD1,546,000USD2,506,000USD1,518,000USD1,530,000USD
Short Term Investments———3,858,000USD—989,000USD——
Net Tangible Assets———142,905,000USD158,202,000USD155,386,000USD128,642,000USD119,887,000USD
Unclassified Current Assets———-3,858,000USD————
Long Term Debt————1,174,000USD2,418,000USD——
Long Term Investments———————1,308,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
Net Income5,118,000USD5,535,000USD5,519,000USD4,884,000USD-321,000USD4,347,000USD1,488,000USD2,490,000USD
Depreciation3,224,000USD3,539,000USD3,500,000USD3,499,000USD4,024,000USD3,536,000USD3,499,000USD3,160,000USD
Stock Based Compensation1,639,000USD1,285,000USD1,638,000USD1,300,000USD1,208,000USD950,000USD1,261,000USD1,369,000USD
Other Non Cash Items2,294,000USD379,000USD-1,933,000USD703,000USD4,858,000USD1,011,000USD3,537,000USD1,162,000USD
Change To Account Receivables-4,094,000USD-2,291,000USD-1,177,000USD-1,786,000USD1,442,000USD397,000USD-1,824,000USD-1,136,000USD
Change To Inventory444,000USD1,473,000USD-2,848,000USD-5,053,000USD1,170,000USD1,280,000USD-277,000USD3,389,000USD
Change In Working Capital-14,798,000USD6,661,000USD-3,187,000USD-5,795,000USD5,311,000USD685,000USD-8,623,000USD-5,834,000USD
Total Cash From Operating Activities-1,846,000USD18,474,000USD4,340,000USD2,609,000USD12,184,000USD9,619,000USD1,305,000USD2,190,000USD
Capital Expenditures-2,480,000USD-1,683,000USD-1,350,000USD-1,110,000USD-2,195,000USD-1,736,000USD-3,351,000USD-3,689,000USD
Free Cash Flow-4,326,000USD16,791,000USD2,990,000USD1,499,000USD9,989,000USD7,883,000USD-2,046,000USD-1,499,000USD
Total Cashflows From Investing Activities-2,480,000USD-1,683,000USD-1,350,000USD-1,110,000USD-2,195,000USD-1,736,000USD-3,351,000USD-3,689,000USD
Net Borrowings0USD0USD0USD0USD0USD0USD——
Total Cash From Financing Activities-1,579,000USD-2,395,000USD-12,122,000USD-731,000USD-576,000USD-1,018,000USD-8,418,000USD107,000USD
Sale Purchase Of Stock-500,000USD-2,022,000USD-11,878,000USD-476,000USD-423,000USD-711,000USD-5,877,000USD-1,848,000USD
Change In Cash-6,313,000USD14,209,000USD-5,141,000USD1,786,000USD5,996,000USD10,009,000USD-9,078,000USD-4,600,000USD
Begin Period Cash Flow93,891,000USD81,345,000USD86,486,000USD84,700,000USD78,704,000USD68,695,000USD77,773,000USD82,373,000USD
End Period Cash Flow87,578,000USD95,554,000USD81,345,000USD86,486,000USD84,700,000USD78,704,000USD68,695,000USD77,773,000USD
Other Cashflows From Investing Activities182,000USD80,000USD-559,000USD——38,000USD—-7,000USD
Other Cashflows From Financing Activities-1,079,000USD-373,000USD-244,000USD-255,000USD-153,000USD-307,000USD-434,000USD-152,000USD
Investments—-1,683,000USD-1,350,000USD-1,110,000USD-2,195,000USD-1,736,000USD-3,351,000USD-3,689,000USD
Unclassified Operating Cash Flow—1,075,000USD-1,197,000USD-1,982,000USD-2,896,000USD———
Unclassified Investing Cash Flow—1,603,000USD1,909,000USD1,110,000USD2,195,000USD1,698,000USD3,351,000USD3,696,000USD
Unclassified Financing Cash Flow——————-2,107,000USD2,107,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income20,451,000USD7,892,000USD15,076,000USD550,000USD30,207,000USD22,958,000USD6,929,000USD-1,202,000USD
Depreciation13,844,000USD14,219,000USD11,816,000USD11,000,000USD11,162,000USD10,743,000USD10,599,000USD9,806,000USD
Stock Based Compensation5,780,000USD4,788,000USD4,893,000USD2,901,000USD3,731,000USD3,787,000USD2,120,000USD2,170,000USD
Other Non Cash Items609,000USD8,522,000USD4,789,000USD6,975,000USD8,377,000USD3,735,000USD6,306,000USD-778,000USD
Change To Account Receivables1,015,000USD-1,121,000USD4,921,000USD-5,942,000USD-1,681,000USD106,000USD375,000USD189,000USD
Change To Inventory-7,824,000USD5,562,000USD995,000USD-8,841,000USD-14,456,000USD-154,000USD-4,870,000USD1,066,000USD
Change In Working Capital-3,090,000USD-8,461,000USD13,177,000USD-27,319,000USD-14,740,000USD793,000USD-21,688,000USD11,855,000USD
Total Cash From Operating Activities35,321,000USD25,298,000USD41,226,000USD710,000USD34,608,000USD37,659,000USD8,545,000USD21,833,000USD
Capital Expenditures-6,480,000USD-10,971,000USD-10,478,000USD-7,628,000USD-6,666,000USD-4,905,000USD-5,104,000USD-4,834,000USD
Free Cash Flow28,841,000USD14,327,000USD30,748,000USD-6,918,000USD27,942,000USD32,754,000USD3,441,000USD16,999,000USD
Total Cashflows From Investing Activities-6,480,000USD-10,971,000USD-10,478,000USD-7,628,000USD-6,612,000USD-4,905,000USD-5,102,000USD211,000USD
Net Borrowings0USD0USD-1,174,000USD-1,546,000USD-2,203,000USD3,406,000USD3,406,000USD-12,181,000USD
Total Cash From Financing Activities-23,773,000USD-9,905,000USD-7,956,000USD-16,246,000USD-31,721,000USD3,878,000USD-63,000USD-12,192,000USD
Sale Purchase Of Stock-16,309,000USD-8,859,000USD-6,397,000USD-13,571,000USD-7,425,000USD0USD257,000USD664,000USD
Change In Cash9,191,000USD2,327,000USD22,341,000USD-26,152,000USD-5,885,000USD38,440,000USD2,991,000USD7,728,000USD
Begin Period Cash Flow84,700,000USD82,373,000USD60,032,000USD86,184,000USD92,069,000USD53,629,000USD50,638,000USD42,910,000USD
End Period Cash Flow93,891,000USD84,700,000USD82,373,000USD60,032,000USD86,184,000USD92,069,000USD53,629,000USD50,638,000USD
Other Cashflows From Investing Activities-6,480,000USD-10,971,000USD—-7,628,000USD54,000USD—2,000USD5,045,000USD
Other Cashflows From Financing Activities-7,464,000USD-1,046,000USD-385,000USD-1,129,000USD-2,235,000USD472,000USD-63,000USD-11,000USD
Unclassified Operating Cash Flow-2,273,000USD-1,662,000USD-8,525,000USD6,603,000USD-4,129,000USD-4,357,000USD4,279,000USD—
Unclassified Investing Cash Flow6,480,000USD21,942,000USD12,128,000USD15,256,000USD6,612,000USD4,905,000USD5,102,000USD—
Investments—-10,971,000USD-12,128,000USD-7,628,000USD-6,612,000USD-4,905,000USD-5,102,000USD211,000USD
Change To Liabilities———-6,985,000USD3,089,000USD8,102,000USD-11,513,000USD12,377,000USD
Dividends Paid———-3,102,000USD-19,858,000USD-19,858,000USD-19,858,000USD-19,858,000USD
Cash And Cash Equivalents Changes———-23,164,000USD-3,725,000USD36,632,000USD3,380,000USD7,728,000USD
Unclassified Financing Cash Flow———3,102,000USD—19,858,000USD16,195,000USD19,194,000USD
Exchange Rate Changes———————-2,124,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q1 2026Quarterly · 2026-03-31ProductCardiovascular Products20,341,000USD0001628280-26-032316
Q1 2026Quarterly · 2026-03-31ProductDigestive Products32,499,000USD0001628280-26-032316
Q1 2026Quarterly · 2026-03-31ProductGeneral Health Products49,070,000USD0001628280-26-032316
Q1 2026Quarterly · 2026-03-31ProductImmunity Products10,145,000USD0001628280-26-032316
Q1 2026Quarterly · 2026-03-31ProductPersonal Care Products6,977,000USD0001628280-26-032316
Q1 2026Quarterly · 2026-03-31ProductWeight Management Products3,860,000USD0001628280-26-032316
Q4 2025Quarterly · 2025-12-31ProductCardiovascular Products18,697,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductDigestive Products37,558,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductGeneral Health Products46,936,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductImmunity Products9,722,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductPersonal Care Products7,567,000USDLegacy provider
Q4 2025Quarterly · 2025-12-31ProductWeight Management Products3,327,000USDLegacy provider
FY 2025Yearly · 2025-12-31ProductCardiovascular Products81,635,000USD0001628280-26-016540
FY 2025Yearly · 2025-12-31ProductDigestive Products124,368,000USD0001628280-26-016540
FY 2025Yearly · 2025-12-31ProductGeneral Health Products192,122,000USD0001628280-26-016540
FY 2025Yearly · 2025-12-31ProductImmunity Products40,818,000USD0001628280-26-016540
FY 2025Yearly · 2025-12-31ProductPersonal Care Products23,267,000USD0001628280-26-016540
FY 2025Yearly · 2025-12-31ProductShipping And Handling2,500,000USD0001628280-26-016540
FY 2025Yearly · 2025-12-31ProductWeight Management Products17,934,000USD0001628280-26-016540
Q3 2025Quarterly · 2025-09-30ProductCardiovascular Products22,965,000USD0000275053-25-000004
Q3 2025Quarterly · 2025-09-30ProductDigestive Products31,370,000USD0000275053-25-000004
Q3 2025Quarterly · 2025-09-30ProductGeneral Health Products51,886,000USD0000275053-25-000004
Q3 2025Quarterly · 2025-09-30ProductImmunity Products10,735,000USD0000275053-25-000004
Q3 2025Quarterly · 2025-09-30ProductPersonal Care Products5,847,000USD0000275053-25-000004
Q3 2025Quarterly · 2025-09-30ProductWeight Management Products5,536,000USD0000275053-25-000004
Q2 2025Quarterly · 2025-06-30ProductCardiovascular Products19,460,000USD0001628280-25-037065
Q2 2025Quarterly · 2025-06-30ProductDigestive Products27,910,000USD0001628280-25-037065
Q2 2025Quarterly · 2025-06-30ProductGeneral Health Products47,376,000USD0001628280-25-037065
Q2 2025Quarterly · 2025-06-30ProductImmunity Products10,086,000USD0001628280-25-037065
Q2 2025Quarterly · 2025-06-30ProductPersonal Care Products5,305,000USD0001628280-25-037065
Q2 2025Quarterly · 2025-06-30ProductWeight Management Products4,613,000USD0001628280-25-037065
Q1 2025Quarterly · 2025-03-31ProductCardiovascular Products20,513,000USD0001628280-26-032316
Q1 2025Quarterly · 2025-03-31ProductDigestive Products27,530,000USD0001628280-26-032316
Q1 2025Quarterly · 2025-03-31ProductGeneral Health Products45,924,000USD0001628280-26-032316
Q1 2025Quarterly · 2025-03-31ProductImmunity Products10,275,000USD0001628280-26-032316
Q1 2025Quarterly · 2025-03-31ProductPersonal Care Products4,548,000USD0001628280-26-032316
Q1 2025Quarterly · 2025-03-31ProductWeight Management Products4,458,000USD0001628280-26-032316
Q4 2024Quarterly · 2024-12-31ProductCardiovascular Products19,131,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductDigestive Products34,619,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductGeneral Health Products46,070,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductImmunity Products12,483,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductPersonal Care Products5,595,000USDLegacy provider
Q4 2024Quarterly · 2024-12-31ProductWeight Management Products307,000USDLegacy provider
FY 2024Yearly · 2024-12-31ProductCardiovascular Products81,700,000USD0001628280-26-016540
FY 2024Yearly · 2024-12-31ProductDigestive Products111,744,000USD0001628280-26-016540
FY 2024Yearly · 2024-12-31ProductGeneral Health Products183,882,000USD0001628280-26-016540
FY 2024Yearly · 2024-12-31ProductImmunity Products38,724,000USD0001628280-26-016540
FY 2024Yearly · 2024-12-31ProductPersonal Care Products17,803,000USD0001628280-26-016540
FY 2024Yearly · 2024-12-31ProductShipping And Handling2,100,000USD0001628280-26-016540
FY 2024Yearly · 2024-12-31ProductWeight Management Products20,511,000USD0001628280-26-016540
Q3 2024Quarterly · 2024-09-30ProductCardiovascular Products21,631,000USD0000275053-25-000004
Q3 2024Quarterly · 2024-09-30ProductDigestive Products26,009,000USD0000275053-25-000004
Q3 2024Quarterly · 2024-09-30ProductGeneral Health Products48,778,000USD0000275053-25-000004
Q3 2024Quarterly · 2024-09-30ProductImmunity Products8,468,000USD0000275053-25-000004
Q3 2024Quarterly · 2024-09-30ProductPersonal Care Products3,761,000USD0000275053-25-000004
Q3 2024Quarterly · 2024-09-30ProductWeight Management Products5,968,000USD0000275053-25-000004
Q2 2024Quarterly · 2024-06-30ProductCardiovascular Products20,079,000USD0001628280-25-037065
Q2 2024Quarterly · 2024-06-30ProductDigestive Products24,697,000USD0001628280-25-037065
Q2 2024Quarterly · 2024-06-30ProductGeneral Health Products45,261,000USD0001628280-25-037065
Q2 2024Quarterly · 2024-06-30ProductImmunity Products8,586,000USD0001628280-25-037065
Q2 2024Quarterly · 2024-06-30ProductPersonal Care Products4,040,000USD0001628280-25-037065
Q2 2024Quarterly · 2024-06-30ProductWeight Management Products7,888,000USD0001628280-25-037065
FY 2023Yearly · 2023-12-31ProductCardiovascular Products83,591,000USD0001628280-25-012082
FY 2023Yearly · 2023-12-31ProductDigestive Products103,866,000USD0001628280-25-012082
FY 2023Yearly · 2023-12-31ProductGeneral Health Products173,774,000USD0001628280-25-012082
FY 2023Yearly · 2023-12-31ProductImmunity Products32,469,000USD0001628280-25-012082
FY 2023Yearly · 2023-12-31ProductPersonal Care Products18,301,000USD0001628280-25-012082
FY 2023Yearly · 2023-12-31ProductShipping And Handling1,400,000USD0001628280-25-012082
FY 2023Yearly · 2023-12-31ProductWeight Management Products33,319,000USD0001628280-25-012082
FY 2020Yearly · 2020-12-31GeographyOther Countries188,188,000USD0000275053-21-000002
FY 2020Yearly · 2020-12-31GeographySouth Korea62,041,000USD0000275053-21-000002
FY 2020Yearly · 2020-12-31GeographyUnited States134,976,000USD0000275053-21-000002
FY 2020Yearly · 2020-12-31SegmentAsia Business138,717,000USD0000275053-21-000002
FY 2020Yearly · 2020-12-31SegmentEurope Business77,688,000USD0000275053-21-000002
FY 2020Yearly · 2020-12-31SegmentLatin America And Other Business Segments23,319,000USD0000275053-21-000002
FY 2020Yearly · 2020-12-31SegmentNorth America Business145,481,000USD0000275053-21-000002
FY 2019Yearly · 2019-12-31GeographyOther Countries163,640,000USD0000275053-21-000002
FY 2019Yearly · 2019-12-31GeographySouth Korea70,556,000USD0000275053-21-000002
FY 2019Yearly · 2019-12-31GeographyUnited States128,019,000USD0000275053-21-000002
FY 2019Yearly · 2019-12-31SegmentAsia Business138,536,000USD0000275053-21-000002
FY 2019Yearly · 2019-12-31SegmentEurope Business62,523,000USD0000275053-21-000002
FY 2019Yearly · 2019-12-31SegmentLatin America And Other Business Segments22,993,000USD0000275053-21-000002
FY 2019Yearly · 2019-12-31SegmentNorth America Business138,163,000USD0000275053-21-000002
Q1 2019Quarterly · 2019-03-31GeographyOther Countries38,783,000USD0001628280-19-006455
Q1 2019Quarterly · 2019-03-31GeographySouth Korea18,528,000USD0001628280-19-006455
Q1 2019Quarterly · 2019-03-31GeographyUnited States33,961,000USD0001628280-19-006455
Q1 2019Quarterly · 2019-03-31SegmentNatures Sunshine Products Americas38,667,000USD0001628280-19-006455
Q1 2019Quarterly · 2019-03-31SegmentNatures Sunshine Products China6,253,000USD0001628280-19-006455
Q1 2019Quarterly · 2019-03-31SegmentNatures Sunshine Products Russia Central And Eastern Europe11,358,000USD0001628280-19-006455
Q1 2019Quarterly · 2019-03-31SegmentSynergy World Wide34,994,000USD0001628280-19-006455
FY 2018Yearly · 2018-12-31GeographyOther Countries158,926,000USD0000275053-20-000009
FY 2018Yearly · 2018-12-31GeographySouth Korea72,207,000USD0000275053-20-000009
FY 2018Yearly · 2018-12-31GeographyUnited States133,677,000USD0000275053-20-000009
FY 2018Yearly · 2018-12-31SegmentLatin America And Other25,201,000USD0000275053-20-000009
FY 2018Yearly · 2018-12-31SegmentNatures Sunshine Products Americas139,031,000USD0000275053-20-000009
FY 2018Yearly · 2018-12-31SegmentNatures Sunshine Products Russia Central And Eastern Europe56,314,000USD0000275053-20-000009
FY 2018Yearly · 2018-12-31SegmentSynergy World Wide144,264,000USD0000275053-20-000009
Q4 2018Quarterly · 2018-12-31GeographyOther Countries45,275,000USDLegacy provider
Q4 2018Quarterly · 2018-12-31GeographySouth Korea19,744,000USDLegacy provider
Q4 2018Quarterly · 2018-12-31GeographyUnited States32,355,000USDLegacy provider

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.